University of Medicine and Pharmacy "Carol Davila", 050474 Bucharest, Romania.
National Institute for Infectious Diseases "Prof. Dr. Matei Bals", 021105 Bucharest, Romania.
Medicina (Kaunas). 2023 Feb 9;59(2):329. doi: 10.3390/medicina59020329.
: Inflammatory bowel diseases are a main focus in current research, with diet being an emerging therapeutic line due to its links in both onset and progression. A Western-style diet high in processed foods, food additives, red meat, and animal fat has been linked to a higher risk of developing IBD. The aim of this study was to establish an association between an anti-inflammatory exclusion diet and maintenance of remission in IBD. Also, we assessed the efficacy and safety of this diet compared to a non-dietary group and the possible therapeutic effect of this diet in the maintenance of IBD remission. : A total of 160 patients with IBD were screened for inclusion, but 21 did not met the inclusion criteria. Thus, 139 patients were assigned to either an exclusion diet or a regular diet according to their choice. : Clinical remission after six months was maintained in the exclusion diet arm (100%). In the control arm, four patients had clinically active disease (one patient with UC and three with CD), and 90 patients maintained the clinical remission state (95.7%) (-value = 0.157). Regarding biochemical markers, ESR at baseline was higher in the exclusion diet arm: 29 (5-62) versus in the control arm 16 (4-48) (-value = 0.019), but six months after, the groups were similar (-value = 0.440). : Patients who followed an exclusion diet maintained clinical remission more frequently. However, the threshold for statistical significance was not achieved. There was also a trend of improvement in inflammation tests in the intervention group.
炎症性肠病是当前研究的重点,饮食作为一种新兴的治疗方法,因其在发病和进展中的作用而受到关注。高加工食品、食品添加剂、红肉和动物脂肪的西式饮食与更高的 IBD 发病风险相关。本研究旨在确定抗炎排除饮食与 IBD 缓解维持之间的关联。此外,我们评估了这种饮食与非饮食组相比的疗效和安全性,以及这种饮食在维持 IBD 缓解中的可能治疗效果。
共有 160 名 IBD 患者被筛选纳入,但有 21 名不符合纳入标准。因此,根据患者选择,将 139 名患者分配到排除饮食组或常规饮食组。
排除饮食组在 6 个月后维持临床缓解(100%)。在对照组中,4 名患者患有临床活动疾病(1 名 UC 和 3 名 CD),90 名患者维持临床缓解状态(95.7%)(-值=0.157)。关于生化标志物,排除饮食组的 ESR 在基线时更高:29(5-62)与对照组 16(4-48)(-值=0.019),但 6 个月后,两组相似(-值=0.440)。
遵循排除饮食的患者更频繁地维持临床缓解。然而,未达到统计学显著水平的阈值。干预组的炎症测试也有改善的趋势。